Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1997 1
1999 1
2008 1
2011 1
2012 2
2013 2
2014 2
2015 1
2016 3
2017 1
2018 2
2019 1
2020 2
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for guillain morgan
Your search for Guillian Morgan retrieved no results
Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Sejvar JJ, et al. Neuroepidemiology. 2011;36(2):123-33. doi: 10.1159/000324710. Epub 2011 Mar 21. Neuroepidemiology. 2011. PMID: 21422765 Free PMC article. Review.
Population incidence of Guillain-Barre syndrome (GBS) is required to assess changes in GBS epidemiology, but published estimates of GBS incidence vary greatly depending on case ascertainment, definitions, and sample size. ...
Population incidence of Guillain-Barre syndrome (GBS) is required to assess changes in GBS epidemiology, but published estimates of G …
Listening to patients in intensive care.
Law D, Morgan M. Law D, et al. Pract Neurol. 2022 Apr;22(2):96-97. doi: 10.1136/practneurol-2021-003255. Epub 2021 Nov 29. Pract Neurol. 2022. PMID: 34845099 No abstract available.
Guillain-Barre Syndrome After Ad26.COV2.S Vaccination.
Thant HL, Morgan R, Paese MM, Persaud T, Diaz J, Hurtado L. Thant HL, et al. Am J Case Rep. 2022 Feb 14;23:e935275. doi: 10.12659/AJCR.935275. Am J Case Rep. 2022. PMID: 35157644 Free PMC article.
However, not unlike previous viral vector vaccines, ongoing clinical trials may unveil rare complications of Ad26.COV2.S. Guillain-Barre Syndrome (GBS) is an autoimmune demyelinating polyneuropathy that can potentially manifest severe neurological symptoms after vaccinatio …
However, not unlike previous viral vector vaccines, ongoing clinical trials may unveil rare complications of Ad26.COV2.S. Guillain-Ba …
Neuromuscular Disorders Associated With COVID-19.
Morgan L, Hollist M, Au K, Ayari L, Betts C, Kirmani BF. Morgan L, et al. Neurosci Insights. 2023 May 25;18:26331055231176251. doi: 10.1177/26331055231176251. eCollection 2023. Neurosci Insights. 2023. PMID: 37255741 Free PMC article. Review.
In this review, we will discuss the relationship between COVID-19 infection and critical illness neuromyopathy, peripheral nerve palsies, myalgias, positional compressive neuropathy, myasthenia gravis, and Guillain-Barre syndrome....
In this review, we will discuss the relationship between COVID-19 infection and critical illness neuromyopathy, peripheral nerve palsies, my …
Guillain-Barre syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Osowicki J, Morgan HJ, Harris A, Clothier HJ, Buttery JP, Kiers L, Crawford NW; SAEFVIC and VicSIS investigators. Osowicki J, et al. Vaccine. 2022 Dec 12;40(52):7579-7585. doi: 10.1016/j.vaccine.2022.10.084. Epub 2022 Nov 7. Vaccine. 2022. PMID: 36357291 Free PMC article.
Guillain-Barre syndrome (GBS) is an adverse event of special interest (AESI) for surveillance systems monitoring adverse events following immunisation (AEFI) with COVID-19 vaccines. ...
Guillain-Barre syndrome (GBS) is an adverse event of special interest (AESI) for surveillance systems monitoring adverse events follo …
COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications.
Kajumba MM, Kolls BJ, Koltai DC, Kaddumukasa M, Kaddumukasa M, Laskowitz DT. Kajumba MM, et al. SN Compr Clin Med. 2020;2(12):2702-2714. doi: 10.1007/s42399-020-00646-w. Epub 2020 Nov 21. SN Compr Clin Med. 2020. PMID: 33251483 Free PMC article. Review.
The concurrence of COVID-19 with Guillain-Barre syndrome (GBS) can increase the likelihood of neuromuscular respiratory failure, autonomic dysfunction, and other life-threatening symptoms. ...
The concurrence of COVID-19 with Guillain-Barre syndrome (GBS) can increase the likelihood of neuromuscular respiratory failure, auto …
Bilateral Facial Spasm Following Guillain-Barre Syndrome.
Guduru Z, Morgan J, Sethi K. Guduru Z, et al. Tremor Other Hyperkinet Mov (N Y). 2018 Apr 24;8:476. doi: 10.7916/D83X9PPX. eCollection 2018. Tremor Other Hyperkinet Mov (N Y). 2018. PMID: 29971193 Free PMC article.
BACKGROUND: We report a patient who developed lower facial muscle spasm at rest and bilateral facial synkinesis several months after treatment of Guillain-Barre syndrome (GBS); this finding, to our knowledge, is hitherto unreported. ...
BACKGROUND: We report a patient who developed lower facial muscle spasm at rest and bilateral facial synkinesis several months after treatme …
The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barre syndrome.
Willison HJ, Halstead SK, Beveridge E, Zitman FM, Greenshields KN, Morgan BP, Plomp JJ. Willison HJ, et al. J Neuroimmunol. 2008 Sep 15;201-202:172-82. doi: 10.1016/j.jneuroim.2008.05.028. Epub 2008 Jul 29. J Neuroimmunol. 2008. PMID: 18664403 Review.
Recent research into the Guillain-Barre syndromes (GBS) has focused on anti-ganglioside antibodies that correlate with specific clinical phenotypes. ...
Recent research into the Guillain-Barre syndromes (GBS) has focused on anti-ganglioside antibodies that correlate with specific clini …
27 results